Translational Neuropharmacology Lab (Zanos Lab) https://validator.w3.org/feed/docs/rss2.html TRACER center (Translational Neuroscience and Behavioural Pharmacology Research Center) New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease? Translational Neuropharmacology Unit Selected Publications New Preprint article – From Heatwaves to Brainwaves: Climate-Driven Microplastics Promote Epstein–Barr Virus Reactivation and Female-Biased Risk for Alzheimer’s Disease and Multiple Sclerosis AI & Systems Bioinformatics Unit Cyprus News New Publication – Linking Misophonia and Tinnitus: Common and Divergent Neurobiological Mechanisms Laboratory/Facilities Director of the Translational Neuropharmacology Lab Dr. Zanos appointed as science communication coordinator for European psychedelics research network Dr. Zanos Appointed to the Editorial Board of the Neuropharmacology Journal Dr. Anna Onisiforou secures €100,000 ERC Vision funding for Multiple Sclerosis research Dr. Andrea Georgiou Clinical Neuropsychopharmacology Unit Ms. Despina Melanthiou Current Research Projects Zanos lab publishes a short review article on Major Depressive Disorder in Trends in Molecular Medicine Current Team Members Dr. Anna Onisiforou Mr. Stylianos Valiantis Ketamine for the prevention of relapse in Opioid Use Disorders (PROUD project) Zanos lab presents PROUD study findings at NeuroGeorgia 2025 international neuroscience conference Scientific symposium: Addressing opioid addiction through interdisciplinary approaches Our Ph.D. student, Despina Melanthiou, featured in national newspaper article on Misophonia research Our Ph.D. student Morfeas Koumas authors public article on Opioid Use Disorder Translational Neuropharmacology Lab awarded €535,000.00 Horizon Europe funding Dr. Andria Michael presents research on ketamine-based therapies for opioid relapse prevention Morfeas Koumas awarded a FENS/IBRO-PERC Fellowship for advanced training in Barcelona Zanos Lab research on ketamine’s therapeutic mechanisms in depression and Opioid Use Disorder was presented in a seminar at the University of Haifa Misophonia Research Presented at the 15th International Conference of the Center for Applied Neuroscience Dr. Zanos Moderated Symposium on Non-Invasive Neuromodulation at 15th International Conference of the Center for Applied Neuroscience Novel Computational Framework Reveals EBV’s Role in Multiple Sclerosis Presented at 15th International Conference of the Center for Applied Neuroscience PROUD Project Presented at the 15th International Conference of the Center for Applied Neuroscience Dr. Zanos was invited to give a talk at the Foundation for Research and Technology in Crete about our ongoing studies on ketamine and opioid use disorders New pre-print: VirTarget framework reveals how Multiple Sclerosis immunotherapies engage with Epstein-Barr Virus-driven disease mechanisms Dr. Zanos was invited and presented on antidepressant mechanisms of action of ketamine and other rapid-acting antidepressants at the 6th German-Cypriot Psychotherapy Conference New preprint: VirTrack framework reveals stage-specific EBV pathogenesis in Multiple Sclerosis Translational Neuropharmacology Lab presents on novel therapies for brain disorders Mr. Sotiris Poyiadjis Dr. Polymnia Louka Mr. Morfeas Koumas Genetic Epidemiology Unit Mr. Markos Apostolakis Featured in Nature Mental Health: Advancing ketamine research and brain pathology treatments Dr. Andria Michael Dr. Eleftheria Charalambous Mr. Tellos Fatta Alumni Welcome to the Zanos Lab – Neuroscience and Pharmacology Research in Cyprus